50 likes | 63 Views
The global Influenza Vaccine market is expected to grow at a compound annual growth rate of 5.51% over the forecast period to reach a market size of US$5.754 billion in 2026 from US$3.953 billion in 2019. Developing mindfulness about medicine and avoidance of flu and an expanding number of government efforts will drive the development of the market in the future. The developing geriatric populace across the globe is additionally expected to expand the interest in influenza vaccines.<br>
E N D
Global Influenza Vaccine Market is projected to grow at a CAGR of 5.51% by 2026 Introduction The global Influenza Vaccine market is expected to grow at a compound annual growth rate of 5.51% over the forecast period to reach a market size of US$5.754 billion in 2026 from US$3.953 billion in 2019. Developing mindfulness about medicine and avoidance of flu and an expanding number of government efforts will drive the development of the market in the future. The developing geriatric populace across the globe is additionally expected to expand the interest in influenza vaccines. Segmentation The global influenza vaccine market has been segmented on the basis of vaccine technology, end- user, and geography. Table of Content 1. Introduction 1.1. Market Definition 1.2. Market Segmentation 2. Research Methodology 2.1. Research Data 2.2. Assumptions 3. Executive Summary
3.1. Research Highlights 4. Market Dynamics 4.1. Market Drivers 4.2. Market Restraints 4.3. Porters Five Forces Analysis 4.3.1. Bargaining Power of Suppliers 4.3.2. Bargaining Power of Buyers 4.3.3. The threat of New Entrants 4.3.4. Threat of Substitutes 4.3.5. Competitive Rivalry in the Function 4.4. Function Value Chain Analysis 5. Global Influenza Vaccine Market, By Vaccine Technology 5.1. Introduction 5.2. Trivalent 5.3. Quadrivalent 6. Global Influenza Vaccine Market, By End-User 6.1. Introduction 6.2. Children 6.3. Adolescents 6.4. Adults 6.5. Elderly 7. Global Influenza Vaccine Market, By Geography
7.1. Introduction 7.2. North America 7.2.1. United States 7.2.2. Canada 7.2.3. Mexico 7.3. South America 7.3.1. Brazil 7.3.2. Argentina 7.3.3. Others 7.4. Europe 7.4.1. UK 7.4.2. Germany 7.4.3. Italy 7.4.4. Spain 7.4.5. Others 7.5. Middle East and Africa 7.5.1. Israel 7.5.2. Saudi Arabia 7.5.3. Others 7.6. Asia Pacific 7.6.1. China 7.6.2. Japan 7.6.3. India 7.6.4. Australia 7.6.5. South Korea 7.6.6. Taiwan 7.6.7. Thailand 7.6.8. Indonesia 7.6.9. Others 8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis 8.2. Emerging Players and Market Lucrativeness 8.3. Mergers, Acquisitions, Agreements, and Collaborations 8.4. Vendor Competitiveness Matrix 9. Company Profiles. 9.1. Seqirus 9.2. GlaxoSmithKline plc. 9.3. Sanofi Pasteur SA. 9.4. Novavax, Inc. 9.5. Emergent BioSolutions Inc. 9.6. CSL Limited 9.7. Pfizer Limited 9.8. Gamma Vaccines Pty Ltd 9.9. BioDiem 9.10. F. Hoffmann-La Roche Ltd Request Free Sample or Download Full Report: global influenza vaccine market TO ORDER OR REQUEST FOR A SAMPLE: PRODUCT: Global Influenza Vaccine Market - Forecasts From 2021 To 2026 Price: US$3,800 – Single User License US$4,400 – Multi User License US$6,800 – Enterprise License To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment. For wire transfer, write to us at sales@knowledge-sourcing.com For any custom requirements or queries, please visit our website or call us:
Website: https://www.knowledge-sourcing.com Contact us: Address: Assotech Business Cresterra, Upper Ground Floor Tower 2, Plot No 22, Sector 135, Noida 201301 Uttar Pradesh, India Email: info@knowledge-sourcing.com Phone: +1-850-250-1698 Follow us: Facebook Linkedin Twitter